Uncertainty From COVID-19 Delays Progress on the Road to Value-Based Cancer Care
October 30th 2020COVID-19 has created a significant distraction from normal practice operations. The uncertainty that comes along with the pandemic is a huge worry, and can distract from practice transformation.
Read More
Clinical Pathways: Reducing Costs and Improving Quality Across a Network
February 19th 2020As the cost of oncology drugs only continues to rise, incorporating clinical pathways into cancer care helps streamline the integration of evidence-based best practices while improving quality and reducing costs for patients and payers.
Read More
Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and Value
February 16th 2017The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Read More